Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2010
05/19/2010EP2185589A2 Immunoglobulin constant region fc receptor binding agents
05/19/2010EP2185587A1 Bone morphogenetic protein (bmp)-binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and use of same
05/19/2010EP2185586A1 Immune modulation via c-type lectin
05/19/2010EP2185585A1 Leptin fusion proteins
05/19/2010EP2185584A1 Interferon fusion proteins
05/19/2010EP2185582A2 Erythropoietin fusion proteins
05/19/2010EP2185579A1 Complexes of grp94 with human immunoglobulin g
05/19/2010EP2185574A2 Antibodies and related molecules that bind to 24p4c12 proteins
05/19/2010EP2185201A1 Compositions and methods for crystallizing antibodies
05/19/2010EP2185199A2 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
05/19/2010EP2185198A1 Lox and l0xl2 inhibitors and uses thereof
05/19/2010EP2185190A1 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
05/19/2010EP2185176A2 Vhz for diagnosis and treatment of cancer
05/19/2010EP1759013B1 Identification of surface-associated antigens for tumor diagnosis and therapy
05/19/2010EP1689783B1 Mutated anti-cd22 antibodies and immunoconjugates
05/19/2010EP1448584B1 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
05/19/2010EP1368060B1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
05/19/2010EP0907735B9 Modulators of tissue regeneration
05/19/2010CN101711256A Antibodies against IL-25
05/19/2010CN101710125A Methods for detecting bicistronic mRNA virus of scylla serrata and kits thereof
05/19/2010CN101710123A Colloidal gold chromatography test paper for detecting residue of ciprofloxacin and preparation method thereof
05/19/2010CN101709303A Gene sequence of k chain of cobia immunoglobulin
05/19/2010CN101709091A Preparation of haplotype antibody of Ang2 and other polymer proteins and application of haplotype antibody in immunodetection method
05/19/2010CN101709090A Matrix protein monoclonal antibody for appraising mineralized stimulating factor and appraising method
05/19/2010CN101709089A Monoclonal antibody for resisting Cyr61 protein and application thereof
05/19/2010CN101709088A Monoclonal antibody for resisting Cyr61 protein and application thereof
05/19/2010CN101709087A Puccinia triticina f.sp.tritic monoclonal antibody and preparation method and application thereof
05/18/2010US7718845 Production of growth hormone in the milk of a transgenic bovine and methods of purification of the growth hormone from the milk
05/18/2010US7718780 monoclonal antibody specific for human NDRG 2 (N-myc downstream regulated gene 2) protein; used to investigate and treat intractable diseases and cancers using the dendritic cell
05/18/2010US7718779 Prophylactic and therapeutic monoclonal antibodies
05/18/2010US7718778 Antibody reactive with human toll like receptor 3
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718776 Comprises monoclonal antibody which specifically binds osteoprotegerin ligand (OPGL) for diagnosis, prevention and treatment of bone disorders
05/18/2010US7718775 Monoclonal antibody with the capability of neutralizing enterovirus type 71 infection
05/18/2010US7718774 TES7 and antibodies that bind thereto
05/18/2010US7718772 Canine thymic stromal lymphopoietin protein and uses thereof
05/18/2010US7718627 Plasmid comprising nucleotide sequences coding immunoglobulin complementary determining regions specific to tumor antigen (5T4); for use in delivering product and/or nucleotide sequences of interest to tumor; drug delivery
05/18/2010US7718400 for increasing insulin sensitivity; decreasing the dose of insulin required for the treatment of diabetes; controlling serum glucose levels; increasing lean tissue mass; increasing overall body strength; and regulating bone resorption
05/18/2010US7718399 Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment
05/18/2010US7718397 Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
05/18/2010US7718382 Method for identifying compounds for treatment of pain
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718179 Ostertagia vaccine
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010US7718175 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains
05/18/2010US7718173 Anti-pro6094 antibodies
05/18/2010US7718172 Preparing monoclonal antibody to interleukins polypeptide for treating and preventing inflammatory bowel, crohn's, arthritis and psoriasis disorders
05/18/2010CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
05/18/2010CA2363965C Protein-induced morphogenesis
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2266429C Hedgehog interacting proteins and uses related thereto
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/18/2010CA2216717C Compositions for the diagnosis, prevention, and treatment of tumor progression
05/14/2010WO2010054403A1 Methods and compositions for treating complement-associated disorders
05/14/2010WO2010054377A2 Fully human antibodies against n-cadherin
05/14/2010WO2010054328A2 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
05/14/2010WO2010054212A1 Engineered antibodies with reduced immunogenicity and methods of making
05/14/2010WO2010054096A1 Method for detecting and purifying pancreatic beta cells
05/14/2010WO2010054010A1 Anti-dll4 antibodies and uses thereof
05/14/2010WO2010053990A2 Crhr2 peptide agonists and uses thereof
05/14/2010WO2010053987A2 Monoclonal antibody production in b cells and uses therof
05/14/2010WO2010053986A1 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
05/14/2010WO2010053877A2 Mhc ii associated protein and uses thereof
05/14/2010WO2010053814A1 Anti-tgf-beta receptor ii antibodies
05/14/2010WO2010053772A2 Disease-associated antigens and methods of use thereof
05/14/2010WO2010053751A1 High affinity human antibodies to human il-4 receptor
05/14/2010WO2010053433A1 Increased expression of specific antigens
05/14/2010WO2010052556A1 Treatment with anti-alpha2 integrin antibodies
05/14/2010WO2010052505A1 Binding members against il-1r1
05/14/2010WO2010052492A1 Vaccine compositions
05/14/2010WO2010052467A2 Canine oral cavity probiotics
05/14/2010WO2010052344A2 Antibodies to modified human igf-1/e peptides
05/14/2010WO2010052288A1 Teneurin and cancer
05/14/2010WO2010052203A1 Modulating neuronal plasticity and treatment of neuronal loss by modulating wnt7a or wnt7b modulation
05/14/2010WO2010052014A1 Treatment of acute lymphoblastic leukemia
05/14/2010WO2010052013A1 Treatment of pediatric acute lymphoblastic leukemia
05/14/2010WO2010051635A1 Methods of improving the therapeutic efficacy and utility of antibody fragments
05/14/2010WO2010051632A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
05/14/2010WO2010031749A9 Compositions and methods for detecting tlr3
05/14/2010WO2010027488A3 Monoclonal antibodies
05/14/2010WO2010022740A3 Hiv-1 envelope polypeptides for hiv vaccine
05/14/2010WO2010011999A3 Methods and compositions for eliciting an amyloid-selective immune response
05/14/2010WO2009040134A8 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
05/14/2010CA2743122A1 Fully human antibodies against n-cadherin
05/14/2010CA2743072A1 Antibodies to modified human igf-1/e peptides
05/14/2010CA2743057A1 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
05/14/2010CA2742969A1 Anti-dll4 antibodies and uses thereof
05/14/2010CA2742961A1 Anti-tgf-beta receptor ii antibodies
05/14/2010CA2742899A1 Treatment with anti-alpha2 integrin antibodies
05/14/2010CA2742861A1 Engineered antibodies with reduced immunogenicity and methods of making
05/14/2010CA2742808A1 Mesothelin antibody protein fusions and methods of use
05/14/2010CA2742802A1 Methods and compositions for treating complement-associated disorders
05/14/2010CA2742777A1 Methods of improving the therapeutic efficacy and utility of antibody fragments
05/14/2010CA2742710A1 Crhr2 peptide agonists and uses thereof
05/14/2010CA2742357A1 Binding members against il-1r1
05/14/2010CA2742249A1 Treatment of acute lymphoblastic leukemia
05/14/2010CA2742242A1 Novel treatment of pediatric acute lymphoblastic leukemia
05/14/2010CA2741691A1 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
05/14/2010CA2737044A1 High affinity human antibodies to human il-4 receptor
05/14/2010CA2689726A1 Antibodies against gpi.alpha.
1 ... 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 ... 1494